- Citations, last 5 years
- 40
- Works, last 5 years
- 14
- h-index
- 18
- Scientists listed
- 1
- Grants since 2016
- 2
Grants received
2025–2026 · research · R43
Preclinical development of VAX024 - a novel targeted combination STING agonist/oncolytic agent
Matthew Giacalone · Vaxiion Therapeutics (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Preclinical Evaluation of VAX014 in Combination with Immune Checkpoint Inhibitors
Steven Fiering · Vaxiion Therapeutics (United States) · funded by National Institutes of Health
